Clinical Trial

Role of Lung Function for Exercise Capacity in Well-trained Individuals

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2025 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the project is to investigate exercise performance in humans following prolonged inhalation of beta2-agonists vilanterol + fluticasone furoate or indacaterol + mometasone furoate
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-04.
Trial Details
NCT Number NCT06077019
Lead Sponsor Morten Hostrup, PhD
Conditions Exercise Performance
Enrollment 60 participants
Start Date 2023-10-03
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-09